Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of fibrinolysis (GO:0051917) | 8.55031293 |
2 | exogenous drug catabolic process (GO:0042738) | 8.53971840 |
3 | negative regulation of fibrinolysis (GO:0051918) | 8.40605163 |
4 | epoxygenase P450 pathway (GO:0019373) | 8.32436506 |
5 | drug catabolic process (GO:0042737) | 7.96649047 |
6 | omega-hydroxylase P450 pathway (GO:0097267) | 7.76641907 |
7 | L-phenylalanine catabolic process (GO:0006559) | 7.68658872 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.68658872 |
9 | regulation of protein activation cascade (GO:2000257) | 7.56424882 |
10 | complement activation, alternative pathway (GO:0006957) | 7.49519949 |
11 | regulation of complement activation (GO:0030449) | 7.23063031 |
12 | glyoxylate metabolic process (GO:0046487) | 7.11205592 |
13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.07524683 |
14 | L-phenylalanine metabolic process (GO:0006558) | 7.07524683 |
15 | protein carboxylation (GO:0018214) | 6.78360235 |
16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.78360235 |
17 | * ethanol oxidation (GO:0006069) | 6.60418723 |
18 | blood coagulation, intrinsic pathway (GO:0007597) | 6.20481702 |
19 | fibrinolysis (GO:0042730) | 6.19859531 |
20 | urea metabolic process (GO:0019627) | 5.83345985 |
21 | drug metabolic process (GO:0017144) | 5.77184546 |
22 | cellular glucuronidation (GO:0052695) | 5.71661870 |
23 | aromatic amino acid family catabolic process (GO:0009074) | 5.67958843 |
24 | negative regulation of sterol transport (GO:0032372) | 5.61018964 |
25 | negative regulation of cholesterol transport (GO:0032375) | 5.61018964 |
26 | uronic acid metabolic process (GO:0006063) | 5.44605984 |
27 | glucuronate metabolic process (GO:0019585) | 5.44605984 |
28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.41272516 |
29 | * ethanol metabolic process (GO:0006067) | 5.37191145 |
30 | regulation of plasminogen activation (GO:0010755) | 5.34058525 |
31 | nitrogen cycle metabolic process (GO:0071941) | 5.30165033 |
32 | serine family amino acid catabolic process (GO:0009071) | 5.26544432 |
33 | bile acid biosynthetic process (GO:0006699) | 5.22284942 |
34 | oxidative demethylation (GO:0070989) | 5.15172625 |
35 | imidazole-containing compound metabolic process (GO:0052803) | 5.07554990 |
36 | protein activation cascade (GO:0072376) | 5.01798962 |
37 | bile acid metabolic process (GO:0008206) | 4.99787676 |
38 | urea cycle (GO:0000050) | 4.97467737 |
39 | regulation of triglyceride catabolic process (GO:0010896) | 4.94109977 |
40 | negative regulation of blood coagulation (GO:0030195) | 4.85965447 |
41 | negative regulation of hemostasis (GO:1900047) | 4.85965447 |
42 | protein-lipid complex remodeling (GO:0034368) | 4.80518706 |
43 | macromolecular complex remodeling (GO:0034367) | 4.80518706 |
44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.80518706 |
45 | intestinal cholesterol absorption (GO:0030299) | 4.78812620 |
46 | cholesterol efflux (GO:0033344) | 4.74664537 |
47 | glycine metabolic process (GO:0006544) | 4.68331931 |
48 | phenylpropanoid metabolic process (GO:0009698) | 4.67076419 |
49 | high-density lipoprotein particle remodeling (GO:0034375) | 4.65119451 |
50 | complement activation, classical pathway (GO:0006958) | 4.64188779 |
51 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.63975766 |
52 | bile acid and bile salt transport (GO:0015721) | 4.61729502 |
53 | triglyceride homeostasis (GO:0070328) | 4.55066595 |
54 | acylglycerol homeostasis (GO:0055090) | 4.55066595 |
55 | complement activation (GO:0006956) | 4.54930798 |
56 | regulation of humoral immune response (GO:0002920) | 4.50973214 |
57 | negative regulation of protein activation cascade (GO:2000258) | 4.48363321 |
58 | negative regulation of coagulation (GO:0050819) | 4.43094331 |
59 | acute-phase response (GO:0006953) | 4.42751360 |
60 | glutamate metabolic process (GO:0006536) | 4.34123942 |
61 | negative regulation of wound healing (GO:0061045) | 4.31611234 |
62 | tyrosine metabolic process (GO:0006570) | 4.29866531 |
63 | regulation of cholesterol esterification (GO:0010872) | 4.29814083 |
64 | phospholipid efflux (GO:0033700) | 4.26738406 |
65 | positive regulation of hemostasis (GO:1900048) | 4.26087259 |
66 | positive regulation of blood coagulation (GO:0030194) | 4.26087259 |
67 | reverse cholesterol transport (GO:0043691) | 4.22545663 |
68 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.18898770 |
69 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.18898770 |
70 | amino-acid betaine metabolic process (GO:0006577) | 4.07841034 |
71 | S-adenosylmethionine metabolic process (GO:0046500) | 4.07677743 |
72 | opsonization (GO:0008228) | 4.03320597 |
73 | cytolysis (GO:0019835) | 4.02235740 |
74 | plasma lipoprotein particle assembly (GO:0034377) | 3.98637073 |
75 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.95418047 |
76 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.95418047 |
77 | negative regulation of lipase activity (GO:0060192) | 3.95255542 |
78 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.91234682 |
79 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.91037351 |
80 | regulation of apoptotic cell clearance (GO:2000425) | 3.89871171 |
81 | positive regulation of coagulation (GO:0050820) | 3.89832140 |
82 | tryptophan catabolic process (GO:0006569) | 3.89558818 |
83 | indole-containing compound catabolic process (GO:0042436) | 3.89558818 |
84 | indolalkylamine catabolic process (GO:0046218) | 3.89558818 |
85 | flavonoid metabolic process (GO:0009812) | 3.86479267 |
86 | alpha-amino acid catabolic process (GO:1901606) | 3.85958692 |
87 | plasma lipoprotein particle organization (GO:0071827) | 3.83538053 |
88 | serine family amino acid metabolic process (GO:0009069) | 3.79093038 |
89 | alkaloid metabolic process (GO:0009820) | 3.75103308 |
90 | plasma lipoprotein particle clearance (GO:0034381) | 3.73550505 |
91 | arginine metabolic process (GO:0006525) | 3.73401320 |
92 | low-density lipoprotein particle remodeling (GO:0034374) | 3.71374992 |
93 | aromatic amino acid family metabolic process (GO:0009072) | 3.69609204 |
94 | negative regulation of complement activation (GO:0045916) | 3.68677044 |
95 | protein-lipid complex subunit organization (GO:0071825) | 3.58981847 |
96 | protein-lipid complex assembly (GO:0065005) | 3.51939693 |
97 | response to mercury ion (GO:0046689) | 3.50435673 |
98 | hormone catabolic process (GO:0042447) | 3.48124061 |
99 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47124013 |
100 | regulation of bile acid biosynthetic process (GO:0070857) | 3.44611846 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.78408713 |
2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.39580783 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.68939595 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.66452567 |
5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.76443433 |
6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.49584674 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.00527425 |
8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.83657054 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.78876122 |
10 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.87064531 |
11 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.57525418 |
12 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.47299289 |
13 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02172282 |
14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.1523317 |
15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66912500 |
16 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.52504898 |
17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.52287539 |
18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.47878635 |
19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43225633 |
20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.37881919 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.31328398 |
22 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.24401165 |
23 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23927813 |
24 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22558474 |
25 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.22403565 |
26 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.14736233 |
27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.12701379 |
28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12225108 |
29 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06730040 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06570187 |
31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02793703 |
32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02320995 |
33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.02126723 |
34 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.98785583 |
35 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.96949070 |
36 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96758598 |
37 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.96384079 |
38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.95061235 |
39 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94431126 |
40 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.93531101 |
41 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89445603 |
42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88929928 |
43 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88838686 |
44 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86640029 |
45 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85361379 |
46 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.82435532 |
47 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81664225 |
48 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.79528783 |
49 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.77849808 |
50 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77508870 |
51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76510178 |
52 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.76235353 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.75833911 |
54 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.71935812 |
55 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.71164154 |
56 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.71079084 |
57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.70750434 |
58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70716979 |
59 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.69706320 |
60 | CBP_21632823_ChIP-Seq_H3396_Human | 0.69419126 |
61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.68779613 |
62 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.68771084 |
63 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68753927 |
64 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.68371537 |
65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.67715347 |
66 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.67403778 |
67 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.65666333 |
68 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.65186269 |
69 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.63255986 |
70 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.63142351 |
71 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.62085265 |
72 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.61838789 |
73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.61493874 |
74 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.61221832 |
75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.60997323 |
76 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.60661104 |
77 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.59602463 |
78 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.59178826 |
79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59127075 |
80 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.59090088 |
81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.58256406 |
82 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.56544865 |
83 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.55972864 |
84 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.55173095 |
85 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.55140427 |
86 | NFYA_21822215_ChIP-Seq_K562_Human | 0.54926552 |
87 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.53703056 |
88 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.53576907 |
89 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53081430 |
90 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52859760 |
91 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.52009079 |
92 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.51144939 |
93 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.50916412 |
94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50510952 |
95 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.49887429 |
96 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.49676596 |
97 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.49595754 |
98 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.49576337 |
99 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49487963 |
100 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.49010848 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 9.54442819 |
2 | MP0005360_urolithiasis | 6.70375619 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.08414009 |
4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.88823775 |
5 | MP0005365_abnormal_bile_salt | 5.77511273 |
6 | MP0003195_calcinosis | 5.07676746 |
7 | MP0003252_abnormal_bile_duct | 3.89054544 |
8 | MP0001666_abnormal_nutrient_absorption | 3.85195377 |
9 | MP0010329_abnormal_lipoprotein_level | 3.34985836 |
10 | MP0002138_abnormal_hepatobiliary_system | 3.23793218 |
11 | MP0003868_abnormal_feces_composition | 3.01420035 |
12 | MP0005332_abnormal_amino_acid | 2.42495614 |
13 | MP0009697_abnormal_copulation | 2.27532882 |
14 | MP0003806_abnormal_nucleotide_metabolis | 2.03481415 |
15 | MP0002876_abnormal_thyroid_physiology | 1.87683630 |
16 | MP0000609_abnormal_liver_physiology | 1.87075683 |
17 | MP0009840_abnormal_foam_cell | 1.86565583 |
18 | MP0010368_abnormal_lymphatic_system | 1.84997003 |
19 | MP0002118_abnormal_lipid_homeostasis | 1.78707904 |
20 | MP0003191_abnormal_cellular_cholesterol | 1.75116537 |
21 | MP0004019_abnormal_vitamin_homeostasis | 1.64439665 |
22 | MP0001764_abnormal_homeostasis | 1.53855643 |
23 | MP0002132_abnormal_respiratory_system | 1.51873295 |
24 | MP0005408_hypopigmentation | 1.47383083 |
25 | MP0005670_abnormal_white_adipose | 1.22793195 |
26 | MP0003656_abnormal_erythrocyte_physiolo | 1.16353685 |
27 | MP0001661_extended_life_span | 1.14131547 |
28 | MP0005319_abnormal_enzyme/_coenzyme | 1.12584540 |
29 | MP0009643_abnormal_urine_homeostasis | 1.08837248 |
30 | MP0000598_abnormal_liver_morphology | 1.02370442 |
31 | MP0005636_abnormal_mineral_homeostasis | 0.99875592 |
32 | MP0009053_abnormal_anal_canal | 0.96572898 |
33 | MP0003879_abnormal_hair_cell | 0.95856105 |
34 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.94185764 |
35 | MP0009642_abnormal_blood_homeostasis | 0.92343103 |
36 | MP0000566_synostosis | 0.91330285 |
37 | MP0003122_maternal_imprinting | 0.89012021 |
38 | MP0005451_abnormal_body_composition | 0.88334836 |
39 | MP0001915_intracranial_hemorrhage | 0.87994567 |
40 | MP0002282_abnormal_trachea_morphology | 0.87196128 |
41 | MP0002971_abnormal_brown_adipose | 0.80276308 |
42 | MP0008872_abnormal_physiological_respon | 0.79480830 |
43 | MP0009763_increased_sensitivity_to | 0.77911087 |
44 | MP0002249_abnormal_larynx_morphology | 0.75393227 |
45 | MP0005376_homeostasis/metabolism_phenot | 0.74447233 |
46 | MP0008469_abnormal_protein_level | 0.72455022 |
47 | MP0000604_amyloidosis | 0.68478914 |
48 | MP0003011_delayed_dark_adaptation | 0.67856100 |
49 | MP0005464_abnormal_platelet_physiology | 0.67215934 |
50 | MP0002078_abnormal_glucose_homeostasis | 0.64926430 |
51 | MP0005395_other_phenotype | 0.64135446 |
52 | MP0002089_abnormal_postnatal_growth/wei | 0.61798153 |
53 | MP0009764_decreased_sensitivity_to | 0.60605477 |
54 | MP0003638_abnormal_response/metabolism_ | 0.59691917 |
55 | MP0003878_abnormal_ear_physiology | 0.58243726 |
56 | MP0005377_hearing/vestibular/ear_phenot | 0.58243726 |
57 | MP0003186_abnormal_redox_activity | 0.55245580 |
58 | MP0005535_abnormal_body_temperature | 0.53612992 |
59 | MP0005334_abnormal_fat_pad | 0.51079004 |
60 | MP0005448_abnormal_energy_balance | 0.50793400 |
61 | MP0002168_other_aberrant_phenotype | 0.49696338 |
62 | MP0005084_abnormal_gallbladder_morpholo | 0.49326222 |
63 | MP0009780_abnormal_chondrocyte_physiolo | 0.49072446 |
64 | MP0004043_abnormal_pH_regulation | 0.48781772 |
65 | MP0000639_abnormal_adrenal_gland | 0.46087665 |
66 | MP0005409_darkened_coat_color | 0.44432782 |
67 | MP0004782_abnormal_surfactant_physiolog | 0.44432593 |
68 | MP0001756_abnormal_urination | 0.43737923 |
69 | MP0003953_abnormal_hormone_level | 0.42744293 |
70 | MP0003718_maternal_effect | 0.42659634 |
71 | MP0005266_abnormal_metabolism | 0.42497565 |
72 | MP0004130_abnormal_muscle_cell | 0.41266761 |
73 | MP0005187_abnormal_penis_morphology | 0.40750061 |
74 | MP0002136_abnormal_kidney_physiology | 0.40337562 |
75 | MP0005058_abnormal_lysosome_morphology | 0.39237871 |
76 | MP0005023_abnormal_wound_healing | 0.39199933 |
77 | MP0009765_abnormal_xenobiotic_induced | 0.38282854 |
78 | MP0005220_abnormal_exocrine_pancreas | 0.37691771 |
79 | MP0009115_abnormal_fat_cell | 0.36590545 |
80 | MP0003690_abnormal_glial_cell | 0.36175991 |
81 | MP0003183_abnormal_peptide_metabolism | 0.34702681 |
82 | MP0000249_abnormal_blood_vessel | 0.33795727 |
83 | MP0006292_abnormal_olfactory_placode | 0.33578988 |
84 | MP0004883_abnormal_blood_vessel | 0.33014610 |
85 | MP0005164_abnormal_response_to | 0.32943095 |
86 | MP0000678_abnormal_parathyroid_gland | 0.32148141 |
87 | MP0003123_paternal_imprinting | 0.28886725 |
88 | MP0009785_altered_susceptibility_to | 0.26517564 |
89 | MP0005647_abnormal_sex_gland | 0.26384287 |
90 | MP0005166_decreased_susceptibility_to | 0.25876691 |
91 | MP0005646_abnormal_pituitary_gland | 0.24858539 |
92 | MP0003075_altered_response_to | 0.24830351 |
93 | MP0008874_decreased_physiological_sensi | 0.24286084 |
94 | MP0000467_abnormal_esophagus_morphology | 0.24043108 |
95 | MP0006036_abnormal_mitochondrial_physio | 0.23360588 |
96 | MP0005551_abnormal_eye_electrophysiolog | 0.22910664 |
97 | MP0002135_abnormal_kidney_morphology | 0.22312865 |
98 | MP0002909_abnormal_adrenal_gland | 0.21846206 |
99 | MP0003172_abnormal_lysosome_physiology | 0.20386659 |
100 | MP0004142_abnormal_muscle_tone | 0.19677885 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Prolonged partial thromboplastin time (HP:0003645) | 9.35240946 |
2 | Complement deficiency (HP:0004431) | 9.23130899 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.11981651 |
4 | Hypobetalipoproteinemia (HP:0003563) | 8.05729418 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.01405418 |
6 | Abnormality of complement system (HP:0005339) | 7.30398472 |
7 | Joint hemorrhage (HP:0005261) | 6.68502528 |
8 | Conjugated hyperbilirubinemia (HP:0002908) | 6.22405414 |
9 | Systemic lupus erythematosus (HP:0002725) | 6.06296041 |
10 | Hyperlipoproteinemia (HP:0010980) | 5.20898673 |
11 | Xanthomatosis (HP:0000991) | 5.18387701 |
12 | Glomerulonephritis (HP:0000099) | 5.16089499 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.95752792 |
14 | Hypolipoproteinemia (HP:0010981) | 4.79544783 |
15 | Intrahepatic cholestasis (HP:0001406) | 4.67712246 |
16 | Spontaneous abortion (HP:0005268) | 4.37452447 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.12228459 |
18 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.09527252 |
19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.87974454 |
20 | Abnormality of the intrinsic pathway (HP:0010989) | 3.83831254 |
21 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.80443105 |
22 | Nephritis (HP:0000123) | 3.60318971 |
23 | Hypercholesterolemia (HP:0003124) | 3.56010920 |
24 | Fat malabsorption (HP:0002630) | 3.53206965 |
25 | Hyperglycinemia (HP:0002154) | 3.39776834 |
26 | Vascular calcification (HP:0004934) | 3.26052059 |
27 | Epidermoid cyst (HP:0200040) | 3.24934522 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 3.22634377 |
29 | Hemorrhage of the eye (HP:0011885) | 3.14828194 |
30 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.07454774 |
31 | Abnormality of glycine metabolism (HP:0010895) | 3.07454774 |
32 | Abnormality of methionine metabolism (HP:0010901) | 3.04119743 |
33 | Osteomalacia (HP:0002749) | 3.03871133 |
34 | Rickets (HP:0002748) | 2.96396066 |
35 | Gingival bleeding (HP:0000225) | 2.86042380 |
36 | Cardiovascular calcification (HP:0011915) | 2.85345102 |
37 | Hyperammonemia (HP:0001987) | 2.84520431 |
38 | Menorrhagia (HP:0000132) | 2.82160892 |
39 | Generalized aminoaciduria (HP:0002909) | 2.77605660 |
40 | Delayed CNS myelination (HP:0002188) | 2.77282586 |
41 | Mitral stenosis (HP:0001718) | 2.77189611 |
42 | Purpura (HP:0000979) | 2.74293846 |
43 | Hyperglycinuria (HP:0003108) | 2.73938765 |
44 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.58301980 |
45 | Thrombophlebitis (HP:0004418) | 2.56388160 |
46 | Steatorrhea (HP:0002570) | 2.47500548 |
47 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46366326 |
48 | Fair hair (HP:0002286) | 2.43869952 |
49 | Abnormality of serum amino acid levels (HP:0003112) | 2.35277014 |
50 | Acanthocytosis (HP:0001927) | 2.34649352 |
51 | Hepatocellular carcinoma (HP:0001402) | 2.30226672 |
52 | Hypophosphatemic rickets (HP:0004912) | 2.27810941 |
53 | Hyperbilirubinemia (HP:0002904) | 2.27305457 |
54 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.27007760 |
55 | Hyperphosphaturia (HP:0003109) | 2.23809714 |
56 | Arthropathy (HP:0003040) | 2.21961118 |
57 | Abnormality of vitamin metabolism (HP:0100508) | 2.18646715 |
58 | Pulmonary embolism (HP:0002204) | 2.18247639 |
59 | Poikilocytosis (HP:0004447) | 2.16907732 |
60 | Abnormality of urine glucose concentration (HP:0011016) | 2.13876369 |
61 | Glycosuria (HP:0003076) | 2.13876369 |
62 | Abnormality of proline metabolism (HP:0010907) | 2.06964218 |
63 | Hydroxyprolinuria (HP:0003080) | 2.06964218 |
64 | Bifid scrotum (HP:0000048) | 2.02133168 |
65 | Metabolic acidosis (HP:0001942) | 2.00247457 |
66 | Deep venous thrombosis (HP:0002625) | 10.6417272 |
67 | Abnormality of the Achilles tendon (HP:0005109) | 1.94412768 |
68 | Neonatal hypoglycemia (HP:0001998) | 1.94188291 |
69 | Enlarged kidneys (HP:0000105) | 1.91967251 |
70 | Ketosis (HP:0001946) | 1.91677560 |
71 | Skin nodule (HP:0200036) | 1.89902094 |
72 | Abnormal urine phosphate concentration (HP:0012599) | 1.88741707 |
73 | Myocardial infarction (HP:0001658) | 1.87627131 |
74 | Abnormality of purine metabolism (HP:0004352) | 1.84914469 |
75 | Gout (HP:0001997) | 1.80302154 |
76 | Reduced antithrombin III activity (HP:0001976) | 1.79550941 |
77 | Potter facies (HP:0002009) | 1.75608335 |
78 | Facial shape deformation (HP:0011334) | 1.75608335 |
79 | Irritability (HP:0000737) | 1.72587428 |
80 | Abnormal tarsal ossification (HP:0008369) | 1.72523386 |
81 | Joint swelling (HP:0001386) | 1.70983626 |
82 | Alkalosis (HP:0001948) | 1.64769985 |
83 | Hypoglycemic coma (HP:0001325) | 1.64737656 |
84 | Elevated alkaline phosphatase (HP:0003155) | 1.60959188 |
85 | Abnormality of iron homeostasis (HP:0011031) | 1.59190774 |
86 | Generalized hypopigmentation of hair (HP:0011358) | 1.58965382 |
87 | Epistaxis (HP:0000421) | 1.58430324 |
88 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.57344463 |
89 | Gangrene (HP:0100758) | 1.56337136 |
90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.55060607 |
91 | Increased serum ferritin (HP:0003281) | 1.54784079 |
92 | Increased mean platelet volume (HP:0011877) | 1.54623521 |
93 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.53597981 |
94 | Proximal tubulopathy (HP:0000114) | 1.52092984 |
95 | Abnormality of carpal bone ossification (HP:0006257) | 1.48971336 |
96 | Blue irides (HP:0000635) | 1.47452144 |
97 | Hypophosphatemia (HP:0002148) | 1.46500894 |
98 | Increased serum pyruvate (HP:0003542) | 1.45769404 |
99 | Pigmentary retinal degeneration (HP:0001146) | 1.44876606 |
100 | Hypochromic anemia (HP:0001931) | 1.44876069 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FGFR4 | 6.36602040 |
2 | FGFR3 | 4.33401742 |
3 | ERN1 | 3.58524327 |
4 | PIK3CA | 3.45726243 |
5 | RIPK1 | 2.81585042 |
6 | WNK4 | 2.73204675 |
7 | ICK | 2.14649563 |
8 | PRKAA2 | 1.99954364 |
9 | BCKDK | 1.94914138 |
10 | AKT3 | 1.93888551 |
11 | MAPK11 | 1.89038155 |
12 | PRKACG | 1.77630535 |
13 | FGFR2 | 1.69334526 |
14 | TGFBR2 | 1.64472145 |
15 | ERBB2 | 1.60074986 |
16 | EPHA4 | 1.53309123 |
17 | SIK1 | 1.52396286 |
18 | ACVR1B | 1.51274059 |
19 | TRIB3 | 1.51199191 |
20 | TYK2 | 1.50088437 |
21 | LATS1 | 1.46802174 |
22 | MAP3K2 | 1.44726020 |
23 | DYRK1B | 1.42614144 |
24 | MST1R | 1.40272029 |
25 | PDPK1 | 1.29844570 |
26 | EPHA3 | 1.29584334 |
27 | FGFR1 | 1.28649967 |
28 | NEK9 | 1.28233015 |
29 | SGK223 | 1.27706835 |
30 | SGK494 | 1.27706835 |
31 | NTRK3 | 1.27517447 |
32 | MAPK15 | 1.25906700 |
33 | MAP2K4 | 1.24747924 |
34 | IGF1R | 1.21828971 |
35 | CDK12 | 1.17848756 |
36 | PRKCG | 1.14782890 |
37 | RET | 1.12396477 |
38 | PINK1 | 1.12111757 |
39 | NLK | 1.10754414 |
40 | PIK3CG | 1.07571053 |
41 | MAPKAPK3 | 1.06740962 |
42 | EPHA2 | 1.04099221 |
43 | STK39 | 1.02422372 |
44 | STK16 | 1.02094560 |
45 | PKN2 | 0.99667174 |
46 | SGK2 | 0.97846085 |
47 | PDK1 | 0.96988456 |
48 | PRKCZ | 0.96155025 |
49 | SGK1 | 0.94477765 |
50 | GRK1 | 0.93672586 |
51 | WNK3 | 0.92377576 |
52 | PRKAA1 | 0.87671115 |
53 | SGK3 | 0.86126162 |
54 | PRKACA | 0.84959118 |
55 | PRKG1 | 0.84562864 |
56 | BRSK2 | 0.81841900 |
57 | EIF2AK1 | 0.80052753 |
58 | CSNK1E | 0.74344305 |
59 | CSF1R | 0.72963142 |
60 | MAP3K3 | 0.70857740 |
61 | MAP4K2 | 0.70683158 |
62 | WNK1 | 0.69009414 |
63 | RPS6KB1 | 0.68428970 |
64 | TYRO3 | 0.66635006 |
65 | FER | 0.62446467 |
66 | ABL2 | 0.61056124 |
67 | DDR2 | 0.60033428 |
68 | SRC | 0.58240603 |
69 | FRK | 0.57902814 |
70 | INSRR | 0.57749442 |
71 | PTK6 | 0.56957107 |
72 | PDGFRA | 0.56477016 |
73 | RPS6KA3 | 0.54733446 |
74 | CSNK1D | 0.54713489 |
75 | TAOK3 | 0.51878754 |
76 | CAMKK2 | 0.51312727 |
77 | PRKCA | 0.51292676 |
78 | MATK | 0.49744101 |
79 | PRKCB | 0.49143779 |
80 | BCR | 0.48383871 |
81 | CSNK2A1 | 0.47612071 |
82 | MAP3K1 | 0.47483199 |
83 | CDK9 | 0.46035403 |
84 | SIK2 | 0.44840037 |
85 | CDC42BPA | 0.44327070 |
86 | TIE1 | 0.43880305 |
87 | CDK6 | 0.41934150 |
88 | MAP2K6 | 0.40596338 |
89 | JAK2 | 0.39970968 |
90 | CSNK2A2 | 0.37876544 |
91 | CSNK1A1 | 0.37110215 |
92 | PRKG2 | 0.36621436 |
93 | MET | 0.35283293 |
94 | MAP3K11 | 0.34309746 |
95 | CDK7 | 0.33854913 |
96 | MAP3K12 | 0.33693562 |
97 | MAP3K5 | 0.33540574 |
98 | GRK6 | 0.33031976 |
99 | JAK1 | 0.31610255 |
100 | PRKACB | 0.30961939 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.41604988 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.05713588 |
3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.01285101 |
4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.58516364 |
5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49557432 |
6 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.31773430 |
7 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.22567864 |
8 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.87150452 |
9 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.82207350 |
10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.70779293 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58750865 |
12 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.52067006 |
13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.51722417 |
14 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.51609730 |
15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.51540944 |
16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.45960182 |
17 | Histidine metabolism_Homo sapiens_hsa00340 | 2.35449102 |
18 | * Tyrosine metabolism_Homo sapiens_hsa00350 | 2.17805473 |
19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98417806 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95224861 |
21 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81723475 |
22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.74632791 |
23 | Bile secretion_Homo sapiens_hsa04976 | 1.74239044 |
24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.71168705 |
25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.68541188 |
26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.64175023 |
27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53274213 |
28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44245808 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40694410 |
30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.36202793 |
31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32951766 |
32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.32214081 |
33 | Peroxisome_Homo sapiens_hsa04146 | 1.29942053 |
34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.24280637 |
35 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.17973672 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15256198 |
37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.12993827 |
38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10804114 |
39 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07357956 |
40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.06871174 |
41 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.01070337 |
42 | Prion diseases_Homo sapiens_hsa05020 | 0.98994837 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98462471 |
44 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97590240 |
45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95540136 |
46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.93425468 |
47 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93410179 |
48 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91117741 |
49 | ABC transporters_Homo sapiens_hsa02010 | 0.89887856 |
50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89357008 |
51 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79003622 |
52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73528809 |
53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72076470 |
54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.72020232 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.63604444 |
56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59330469 |
57 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51243305 |
58 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48959595 |
59 | Lysine degradation_Homo sapiens_hsa00310 | 0.47630943 |
60 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.44188640 |
61 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43662601 |
62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.37252255 |
63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.32830032 |
64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.31609007 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.30937866 |
66 | Pertussis_Homo sapiens_hsa05133 | 0.28140251 |
67 | Insulin resistance_Homo sapiens_hsa04931 | 0.26767517 |
68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26050274 |
69 | Mineral absorption_Homo sapiens_hsa04978 | 0.22228886 |
70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21156054 |
71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20194899 |
72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.18885697 |
73 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18527809 |
74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.18223256 |
75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13944188 |
76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12258616 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.10282594 |
78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08958310 |
79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08506272 |
80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06471805 |
81 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.06432871 |
82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.06200420 |
83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.03871527 |
84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01165984 |
85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2423094 |
86 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1946257 |
87 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1942084 |
88 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1866202 |
89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1785326 |
90 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1686105 |
91 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1668788 |
92 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1157111 |
93 | Amoebiasis_Homo sapiens_hsa05146 | -0.1084962 |
94 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.0992092 |
95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0983608 |
96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0982486 |
97 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0790155 |
98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0717893 |
99 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0133400 |
100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0115775 |